Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Human melanoma antigen AH is an autoantigenic ganglioside related to GD2.

Literature DB >> 7175442

Human melanoma antigen AH is an autoantigenic ganglioside related to GD2.

T Watanabe, C S Pukel, H Takeyama, K O Lloyd, H Shiku, L T Li, L R Travassos, H F Oettgen, L J Old.

Abstract

AH antigen, initially defined by an antibody present in a melanoma patient, is a cell surface antigen found on approximately 65% of melanoma cell lines. Absorption analysis indicates that AH is a differentiation antigen marking normal and malignant cells of neuroectodermal origin. The AH determinant has been found to be related to GD2 ganglioside.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 1982 PMID： 7175442 PMCID： PMC2186856 DOI： 10.1084/jem.156.6.1884

Source DB: PubMed Journal: J Exp Med ISSN： 0022-1007 Impact factor: 14.307

19 in total

1. High-performance thin-layer chromatography and densitometric determination of brain ganglioside compositions of several species.

Authors: S Ando; N C Chang; R K Yu
Journal: Anal Biochem Date: 1978-09 Impact factor: 3.365

2. Anti-Pr3: serological and immunochemical identification of a new anti-Pr subspecificity.

Authors: D Roelcke; W Ebert; H P Geisen
Journal: Vox Sang Date: 1976 Impact factor: 2.144

3. Isolation and characterization of a novel trisialoganglioside, GT1a, from human brain.

Authors: S Ando; R K Yu
Journal: J Biol Chem Date: 1977-09-25 Impact factor: 5.157

4. Immunochemical studies on blood groups. LIV. Classification of anti-I and anti-i sera into groups based on reactivity patterns with various antigens related to the blood group A,B,H, Le a, Le b and precursor substances.

Authors: T Feizi; E A Kabat
Journal: J Exp Med Date: 1972-06-01 Impact factor: 14.307

5. A Waldenström macroglobulin that is both a cold agglutinin and a cryoglobulin because it binds N-acetylneuraminosyl residues.

Authors: C M Tsai; D A Zopf; R K Yu; R Wistar; V Ginsburg
Journal: Proc Natl Acad Sci U S A Date: 1977-10 Impact factor: 11.205

6. Reaction of antibodies that cause paroxysmal cold hemoglobinuria (PCH) with globoside and Forssman glycosphingolipids.

Authors: G A Schwarting; S K Kundu; D M Marcus
Journal: Blood Date: 1979-02 Impact factor: 22.113

7. Serological identification of the new cold agglutinin specificity anti-Gd.

Authors: D Roelcke; W Riesen; H P Geisen; W Ebert
Journal: Vox Sang Date: 1977 Impact factor: 2.144

8. A human cold agglutinin which binds lacto-N-neotetraose.

Authors: C M Tsai; D A Zopf; R Wistar; V Ginsburg
Journal: J Immunol Date: 1976-09 Impact factor: 5.422

9. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.

Authors: T E Carey; T Takahashi; L A Resnick; H F Oettgen; L J Old
Journal: Proc Natl Acad Sci U S A Date: 1976-09 Impact factor: 11.205

10. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens.

Authors: H Shiku; T Takahashi; H F Oettgen
Journal: J Exp Med Date: 1976-10-01 Impact factor: 14.307

33 in total

1. Autologous typing: a tedious but orthodox approach for defining human tumor antigens with clarity.

Authors: Hiroshi Shiku; Toshitada Takahashi
Journal: Cancer Immun Date: 2012-05-01

2. Detection of disease specific sialoglycoconjugate specific antibodies in bronchoalveolar lavage fluid of non-small cell lung cancer patients.

Authors: Sangeeta Mehta; Rakhee Chhetra; Radhika Srinivasan; Suresh C Sharma; Digambar Behera; Sujata Ghosh
Journal: Glycoconj J Date: 2010-05-16 Impact factor: 2.916

Review 3. Trial Watch: Adoptively transferred cells for anticancer immunotherapy.

Authors: Carole Fournier; François Martin; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi; Lionel Apetoh
Journal: Oncoimmunology Date: 2017-08-11 Impact factor: 8.110

4. Induction of IgG antibodies against GD3 ganglioside in rabbits by an anti-idiotypic monoclonal antibody.

Authors: P B Chapman; A N Houghton
Journal: J Clin Invest Date: 1991-07 Impact factor: 14.808

5. Cell-surface antigens of melanoma recognized by human monoclonal antibodies.

Authors: H Yamaguchi; K Furukawa; S R Fortunato; P O Livingston; K O Lloyd; H F Oettgen; L J Old
Journal: Proc Natl Acad Sci U S A Date: 1987-04 Impact factor: 11.205

6. Modulation of tumor growth by inhibitory Fc(gamma) receptor expressed by human melanoma cells.

Authors: Lydie Cassard; Joël F G Cohen-Solal; Annie Galinha; Xavier Sastre-Garau; Claire Mathiot; Jérôme Galon; Thierry Dorval; Alain Bernheim; Wolf H Fridman; Catherine Sautès-Fridman
Journal: J Clin Invest Date: 2002-11 Impact factor: 14.808

7. Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice.

Authors: Assefa Wondimu; Tianqian Zhang; Thomas Kieber-Emmons; Phyllis Gimotty; Katrin Sproesser; Rajasekharan Somasundaram; Soldano Ferrone; Chun-Yen Tsao; Dorothee Herlyn
Journal: Cancer Immunol Immunother Date: 2008-07 Impact factor: 6.968

8. GD2 ganglioside on human T-lymphotropic virus type I-infected T cells: possible activation of beta-1,4-N-acetylgalactosaminyltransferase gene by p40tax.

Authors: K Furukawa; T Akagi; Y Nagata; Y Yamada; K Shimotohno; N K Cheung; H Shiku; K Furukawa
Journal: Proc Natl Acad Sci U S A Date: 1993-03-01 Impact factor: 11.205

9. Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.

Authors: P O Livingston; E J Natoli; M J Calves; E Stockert; H F Oettgen; L J Old
Journal: Proc Natl Acad Sci U S A Date: 1987-05 Impact factor: 11.205

10. Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma. Treatment of stage II melanoma with viral lysates.

Authors: P Hersey; A Edwards; A Coates; H Shaw; W McCarthy; G Milton
Journal: Cancer Immunol Immunother Date: 1987 Impact factor: 6.968